These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 26905690)
1. Time Course of Pupil Center Location after Ocular Drug Application. Hoang TA; Macdonnell JE; Mangan MC; Monsour CS; Polwattage BL; Wilson SF; Suheimat M; Atchison DA Optom Vis Sci; 2016 Jun; 93(6):594-9. PubMed ID: 26905690 [TBL] [Abstract][Full Text] [Related]
2. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Eyeson-Annan ML; Hirst LW; Battistutta D; Green A Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648 [TBL] [Abstract][Full Text] [Related]
3. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial. Trinavarat A; Pituksung A Indian J Ophthalmol; 2009; 57(5):351-4. PubMed ID: 19700872 [TBL] [Abstract][Full Text] [Related]
4. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation. Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877 [TBL] [Abstract][Full Text] [Related]
7. Should the pupil be used as a fixed reference for instrument alignment? Schachar RA J Cataract Refract Surg; 2005 Nov; 31(11):2040-1. PubMed ID: 16412898 [No Abstract] [Full Text] [Related]
8. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone. Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment. Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086 [TBL] [Abstract][Full Text] [Related]
10. A combination solution for routine pupillary dilation. Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239 [TBL] [Abstract][Full Text] [Related]
11. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%. Motta MM; Coblentz J; Fernandes BF; Burnier MN Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547 [TBL] [Abstract][Full Text] [Related]
12. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye. Stadtbäumer K; Frommlet F; Nell B Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758 [TBL] [Abstract][Full Text] [Related]
13. The effects on pupil size and accommodation of sympathetic and parasympatholytic agents. Paggiarino DA; Brancato LJ; Newton RE Ann Ophthalmol; 1993 Jul; 25(7):244-9, 253. PubMed ID: 8363290 [TBL] [Abstract][Full Text] [Related]
14. Phenylephrine 5% added to tropicamide 0.5% eye drops does not influence retinal oxygen saturation values or retinal vessel diameter in glaucoma patients. Vandewalle E; Abegão Pinto L; Olafsdottir OB; Stalmans I Acta Ophthalmol; 2013 Dec; 91(8):733-7. PubMed ID: 22998076 [TBL] [Abstract][Full Text] [Related]
15. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer. Taneri S; Oehler S; Azar DT J Refract Surg; 2011 Sep; 27(9):678-85. PubMed ID: 21446641 [TBL] [Abstract][Full Text] [Related]
16. Changes in the shape of the anterior and posterior corneal surfaces caused by mydriasis and miosis: detailed analysis. Saitoh K; Yoshida K; Hamatsu Y; Tazawa Y J Cataract Refract Surg; 2004 May; 30(5):1024-30. PubMed ID: 15130639 [TBL] [Abstract][Full Text] [Related]
18. Effects of mydriasis and miosis on kinetic perimetry findings in normal participants. Hirasawa K; Shoji N; Kobashi C; Yamanashi A Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1341-6. PubMed ID: 25981119 [TBL] [Abstract][Full Text] [Related]
19. The comparison of mydriatic effect between two drugs of different mechanism. Park JH; Lee YC; Lee SY Korean J Ophthalmol; 2009 Mar; 23(1):40-2. PubMed ID: 19337478 [TBL] [Abstract][Full Text] [Related]
20. Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation. Liu JC; Green W; Van Stavern GP; Culican SM Can J Ophthalmol; 2017 Aug; 52(4):349-354. PubMed ID: 28774515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]